参考文献/References:
[1] Erem C,Civan N,Coskun H,et al.Signal peptide-CUB-EGF domain-containing protein 1(SCUBE1)levels in patients with overt and subclinical hyperthyroidism:effects of treatment[J].Clin Endocrinol,2016,84(6):919-924.DOI:10.1111/cen.12955. Epub 2015 Nov 12.
[2] 陈海兰,高宇.甲状腺功能亢进症合并心血管疾病研究进展[J].中国老年学杂志,2016,36(16):4122-4124.DOI:10.3969/j.issn.1005-9202.2016.16.117.
[3] 葛均波,徐永健,王辰.内科学[M].第9版.北京:人民卫生出版社,2018:302-302.
[4] Kortekaas KA,van der Lienden B,Jong S,et al.Graves' disease as an uncommon cause of acute pericarditis[J].BMJ Case Rep,2014,2014:bcr2013203342.DOI:10.1136/bcr-2013-203342.
[5] Gondal M,Hussain A,Yousuf H,et al.Double trouble-thyro-pericarditis:rare presentation of Graves' disease as pericarditis—a case report[J].Eur Heart J Case Rep,2020,4(6):1-5.DOI:10.1093/ehjcr/ytaa280.
[6] 赵丹青,左志华,张冲,等.甲巯咪唑治疗Graves病甲状腺功能亢进症致肌酸激酶增高2例报告[J].江苏大学学报(医学版),2017,27(3):274-276.DOI:10.13312/j.issn.1671-7783.y170120.
[7] 张云峰.甲巯咪唑所致肌病1例报告并文献复习[J].西南军医,2012,14(2):271.DOI:j.issn.1672-7193.2012.043.
[8] Page SR,Nussey SS.Myositis in association with carbimazole therapy[J].Lancet,1989,1(8644):964.DOI:10.1016/s0140-6736(89)92550-6.
[9] 何志忠,王全兴,白雅彬,等.抗甲状腺药物治疗甲亢所致血清肌酸激酶升高及肌痛的临床观察[J].基层医学论坛,2021,25(31):4529-4530.DOI:10.19435/j.1672-1721.2021.31.037.
[10] 邓旭,魏吉林,程程,等.甲巯咪唑治疗甲状腺功能亢进症导致肌酸激酶升高1例[J].临床合理用药杂志,2020,13(22):101,103.DOI:10.15887/j.cnki.13-1389/r.2020.22.045.
[11] Lu R,Wang H,Hong T,et al.Myopathy after rapid correction of hyperthyroidism:a case report and review of literature[J].Medicine(Baltimore),2020,99(3):e18878.DOI:10.1097/MD.0000000000018878.
[12] Benavides VC,Rivkees SA.Myopathy associated with acute hypothyroidism following radioiodine therapy for Graves disease in an adolescent[J].Int J Pediatr Endocrinol,2010,2010:717303.DOI:10.1155/2010/717303.
[13] 程莹.甲巯咪唑治疗甲状腺功能亢进症后肌酸激酶升高三例报告并文献复习[J].中国全科医学,2018,21(30):3781-3784.DOI:10.12114/j.issn.1007-9572.2018.00.203.
[14] Hargreaves IP,Mantle D.Targeted treatment of age-related fibromyalgia with supplemental coenzyme Q10[J].Adv Exp Med Biol,2021,1286:77-85.DOI:10.1007/978-3-030-55035-6_5.